The Nano-biotechnology Market is estimated at US$54.7 billion in 2026 and is projected to grow at a CAGR of 9.9% to reach US$116.4 billion by 2034.
Relevant uses and settings include drug delivery, molecular diagnostics, biosensors, regenerative medicine, imaging support, and life science research platforms. Commercial considerations include regulatory uncertainty, manufacturing scale up, safety evaluation complexity, and difficulty translating promising research into broad commercial adoption.
This product will be delivered within 1-3 business days.
Market Overview
The Nano-biotechnology Market covers biotechnology applications that use nanoscale materials and structures for diagnostics, therapeutics, delivery systems, biosensing, and advanced biological research.Relevant uses and settings include drug delivery, molecular diagnostics, biosensors, regenerative medicine, imaging support, and life science research platforms. Commercial considerations include regulatory uncertainty, manufacturing scale up, safety evaluation complexity, and difficulty translating promising research into broad commercial adoption.
Market Segmentation
By Application
- Drug Delivery
- Diagnostics & Imaging
- Regenerative Medicine & Tissue Engineering
- Agriculture & Food Safety
- Environmental Remediation
By End-User Industry
- Pharmaceuticals & Biotechnology Firms
- Hospitals & Diagnostic Centers
- Academic & Research Institutes
- Agriculture & Food Processing Companies
- Environmental & Energy Enterprises
By Nanomaterial Type
- Lipid-based Nanocarriers
- Polymeric Nanoparticles
- Metallic Nanoparticles
- Carbon-based Nanomaterials (CNT, Graphene, Q-dots)
- DNA/RNA Origami Structures
Key Companies Analysed
- Thermo Fisher Scientific
- Merck KGaA
- Danaher
- Agilent Technologies
- Abbott
- Roche
- Illumina
- QIAGEN
- Bruker
- Bio-Rad Laboratories
- Revvity
- Cytiva
- NanoString Technologies
- Oxford Nanopore Technologies
- Creative Diagnostics
- nanoComposix
- CD Bioparticles
- Fortis Life Sciences
- Standard BioTools
- SomaLogic
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Nano-biotechnology Market Overview
3. Nano-biotechnology Market Dynamics
4. Nano-biotechnology Market Strategic Analysis
5. Global Nano-biotechnology Market Size, Share and Forecast, 2025-2034
6. North America Nano-biotechnology Market Outlook to 2034
7. Europe Nano-biotechnology Market Outlook to 2034
8. Asia-Pacific Nano-biotechnology Market Outlook to 2034
9. Middle East and Africa Nano-biotechnology Market Outlook to 2034
10. South and Central America Nano-biotechnology Market Outlook to 2034
11. Nano-biotechnology Market Competitive Landscape
12. Appendix
Companies Mentioned
- Thermo Fisher Scientific
- Merck KGaA
- Danaher
- Agilent Technologies
- Abbott
- Roche
- Illumina
- QIAGEN
- Bruker
- Bio-Rad Laboratories
- Revvity
- Cytiva
- NanoString Technologies
- Oxford Nanopore Technologies
- Creative Diagnostics
- nanoComposix
- CD Bioparticles
- Fortis Life Sciences
- Standard BioTools
- SomaLogic
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 54.7 Billion |
| Forecasted Market Value ( USD | $ 116.4 Billion |
| Compound Annual Growth Rate | 9.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
